Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk Factors Predicting Amyloid PET Positivity in Patients with Mild Cognitive Impairment and Apolipoprotein E ɛ3/ɛ3 Genotypes.

Journal of Alzheimer's disease : JAD - 1 Jan 2020

Ho Seong Hee, Yang Dong-Won

Abstract excerpt

BACKGROUND: The apolipoprotein E (APOE) ɛ4 allele is a well-known risk factor for AD and is associated with higher amyloid deposition and earlier dementia onset. However, the relationship between amyloid pathology and the most common APOE allele, ɛ3, has not been well studied. OBJECTIVE: In this study, we aimed to identify the risk factors predicting amyloid PET positivity in patients with mild cognitive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Amyloid beta-Peptides
Share to Apolipoprotein E3

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cognitive Dysfunction

Share to Magnetic Resonance Imaging

Share to Positron-Emission Tomography

Share to Predictive Value of Tests

Share to Risk Factors

Source

Identifiers

PMID: 32804143
DOI: 10.3233/JAD-200439

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk Factors Predicting Amyloid PET Positivity in Patients with Mild Cognitive Impairment and Apolipoprotein E ɛ3/ɛ3 Genotypes.PMID 32804143Read ↗

Predicting amyloid-PET positivity and clinical conversion in APOE ε3/ε3 non-demented individuals with multimodal factorsSemantic proximity Read ↗

Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer's disease.Semantic proximity Read ↗

The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI)Semantic proximity Read ↗

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.Semantic proximity Read ↗

Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, APOE genotype and sex.Semantic proximity Read ↗

Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.Semantic proximity Read ↗

Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.Semantic proximity Read ↗

Differences in Alzheimer's Disease-Related Pathology Profiles Across Apolipoprotein Groups.Semantic proximity Read ↗

APOE and amyloid-tau pathology in cognitively unimpaired older adultsSemantic proximity Read ↗

Differential Associations of APOEɛ2 and APOEɛ4 Genotypes with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease in Individuals Without Dementia.Semantic proximity Read ↗

APOE interacts with tau PET to influence memory independently of amyloid PETSemantic proximity Read ↗

Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.